Study Links Certain High-density Lipoproteins, Better Survival in PAH Patients
Higher levels of certain high-density lipoproteins (HDLs) improve the survival of pulmonary arterial hypertension (PAH) patients, according to a recent evaluation of two PAH patient cohorts. Targeting certain HDL subclasses may improve future PAH treatment. The study, “Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary…